Trials / Completed
CompletedNCT02282579
Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy
Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy, in Patients With Metastatic Renal Cell Carcinoma in Daily Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Spanish Oncology Genito-Urinary Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this retrospective observational study was to analyze the effect of targeted therapies administered as second-line treatment after failure of pazopanib as well as increase the amount of information available on efficacy and safety of pazopanib as a first-line therapy in practice usual for the clinical treatment of metastatic Renal Carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pazopanib | Non interventional study |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-02-01
- Completion
- 2015-04-01
- First posted
- 2014-11-04
- Last updated
- 2018-04-26
Locations
34 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02282579. Inclusion in this directory is not an endorsement.